RT Journal Article
SR Electronic
T1 High Expression of Phospho-H2AX Predicts a Poor Prognosis in Colorectal Cancer
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 2447
OP 2453
VO 35
IS 4
A1 YI-CHEN LEE
A1 TZU CHIEH YIN
A1 YI-TING CHEN
A1 CHEE-YIN CHAI
A1 JAW YUAN WANG
A1 MEI-CHI LIU
A1 YUAN-CHIEN LIN
A1 JUNG YU KAN
YR 2015
UL http://ar.iiarjournals.org/content/35/4/2447.abstract
AB Background/Aim: Colorectal cancer (CRC) is one of the most common causes of cancer-related deaths worldwide. DNA double-strand breaks (DSBs) are deleterious lesions that can lead to chromosomal anomalies, genomic instability and cancer. The histone H2AX plays an important role in response to DNA damage and phosphorylation of H2AX (p-H2AX) is evidence of DSBs. The aim of this study was to evaluate the clinical significance of p-H2AX expression in CRC. Patients and Methods: p-H2AX expression in CRC tissues was analyzed by immunohistochemistry and correlated with clinicopathological variables using the chi-square test. The prognostic value of p-H2AX for distant metastasis-free survival (DMFS) and overall survival (OS) was evaluated by Kaplan-Meier estimates and the individual prognostic components were analyzed with Cox regression analysis. Results: A high p-H2AX expression in CRC tissues was associated with tumor stage and perineurial invasion. Furthermore, a high p-H2AX expression was associated with poor DMFS and OS. Cox regression analysis also revealed that p-H2AX was an independent predictor of DMFS and OS. Conclusion: A high p-H2AX expression in CRC tissues is associated with a more malignant cancer behavior, as well as poor patient survival. p-H2AX may, therefore, be an independent prognostic predictor for CRC, as well as a potential therapeutic target.